Correlation Between Neumora Therapeutics, and Sun Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neumora Therapeutics, and Sun Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neumora Therapeutics, and Sun Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neumora Therapeutics, Common and Sun Life Financial, you can compare the effects of market volatilities on Neumora Therapeutics, and Sun Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neumora Therapeutics, with a short position of Sun Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neumora Therapeutics, and Sun Life.

Diversification Opportunities for Neumora Therapeutics, and Sun Life

-0.21
  Correlation Coefficient

Very good diversification

The 3 months correlation between Neumora and Sun is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Neumora Therapeutics, Common and Sun Life Financial in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sun Life Financial and Neumora Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neumora Therapeutics, Common are associated (or correlated) with Sun Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sun Life Financial has no effect on the direction of Neumora Therapeutics, i.e., Neumora Therapeutics, and Sun Life go up and down completely randomly.

Pair Corralation between Neumora Therapeutics, and Sun Life

Given the investment horizon of 90 days Neumora Therapeutics, Common is expected to under-perform the Sun Life. In addition to that, Neumora Therapeutics, is 11.72 times more volatile than Sun Life Financial. It trades about -0.13 of its total potential returns per unit of risk. Sun Life Financial is currently generating about 0.09 per unit of volatility. If you would invest  5,617  in Sun Life Financial on October 24, 2024 and sell it today you would earn a total of  274.00  from holding Sun Life Financial or generate 4.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Neumora Therapeutics, Common  vs.  Sun Life Financial

 Performance 
       Timeline  
Neumora Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neumora Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Sun Life Financial 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Sun Life Financial are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable essential indicators, Sun Life is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.

Neumora Therapeutics, and Sun Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neumora Therapeutics, and Sun Life

The main advantage of trading using opposite Neumora Therapeutics, and Sun Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neumora Therapeutics, position performs unexpectedly, Sun Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sun Life will offset losses from the drop in Sun Life's long position.
The idea behind Neumora Therapeutics, Common and Sun Life Financial pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Commodity Directory
Find actively traded commodities issued by global exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators